Key result
Low-frequency PELI3 variant A307V linked to ~86% lower risk of advanced AMD.
Why the study?
Substantial heritability of advanced age-related macular degeneration remains unexplained despite discovery of over 20 common frequency alleles by genome-wide association studies.
Are specific coding variants in CFH, PELI3, and near CTRB1 associated with the risk of advanced age-related macular degeneration?
Case-Control (n=29,600)
Yes
Are specific coding variants in CFH, PELI3, and near CTRB1 associated with the risk of advanced age-related macular degeneration?
Identification of protective coding variants in PELI3, CFH, and near CTRB1 expands the understanding of genetic factors and potential pathways (HDL and innate immunity) involved in age-related macular degeneration.
Answers are grounded in this paper and cite their sources.
Supports PELI3 as a novel protective locus in advanced AMD; extends genetic insights into innate immunity but should not yet alter clinical practice.
Although >20 common frequency age-related macular degeneration (AMD) alleles have been discovered with genome-wide association studies, substantial disease heritability remains unexplained. In this study we sought to identify additional variants, both common and rare, that have an association with advanced AMD. We genotyped 4,332 cases and 25,268 controls of European ancestry from three different populations using the Illumina Infinium HumanExome BeadChip. We performed meta-analyses to identify associations with common variants and performed single variant and gene-based burden tests to identify associations with rare variants. Two protective, low frequency, non-synonymous variants A307V in PELI3 (odds ratio [OR]=0.14, P =4.3×10 −10 ) and N1050Y in CFH (OR=0.76, P conditional =1.6×10 −11 ) were significantly associated with a decrease in risk of AMD. Additionally, we identified an enrichment of protective alleles in PELI3 using a burden test (OR=0.14). The new variants have a large effect size, similar to rare mutations we reported previously in a targeted sequencing study, which remain significant in this analysis: CFH R1210C (OR=18.82, P =3.5×10 −07 ), C3 K155Q (OR=3.27, P =1.5×10 −10 ), and C9 P167S (OR=2.04, P =2.8×10 −07 ). We also identified a strong protective signal for a common variant (rs8056814) near CTRB1 associated with a decrease in AMD risk (logistic regression: OR = 0.71, P = 1.8x10 −07 ; Firth corrected OR = 0.64, P = 9.6x10 −11 ). This study supports the involvement of both common and low frequency protective variants in AMD. It also may expand the role of the high-density lipoprotein pathway and branches of the innate immune pathway, outside that of the complement system, in the etiology of AMD.
No takes yet. Share an insight, caveat, or question.
Wagner et al. (2015) conducted a case-control in Age-related macular degeneration (n=29,600). PELI3 A307V variant vs. Non-carriers / Reference allele was evaluated on Risk of advanced age-related macular degeneration (OR 0.14, p=4.3x10-10). The low frequency, non-synonymous variant A307V in PELI3 is associated with a decreased risk of advanced age-related macular degeneration.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: